Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
OMAHA, Neb. (AP) — The University of Nebraska's medical school is seeking 25 people for a study of a medication derived from marijuana.
The University of Nebraska Medical Center in Omaha says the study will investigate the use of cannabidiol in patients with drug-resistant epilepsy who also will take anti-epileptic drugs.
Cannabidiol is extracted from the marijuana plant — Cannabis sativa — and is distinct from the component that makes people high. The study medication is called Epidiolex. It's described as a plant-based pharmaceutical formulation of pure cannabidiol and contains only trace amounts of the psychoactive component.
The study is authorized under a legislative bill approved in 2015.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
